# reload+after+2024-01-23 12:46:26.280416
address1§201 East Fifth Street
address2§Suite 1900
city§Cincinnati
state§OH
zip§45202
country§United States
phone§513 620 4101
website§https://onconetix.gcs-web.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Onconetix, Inc., a biotechnology and pharmaceutical company, focuses on developing and commercializing transformational therapies to address health challenges worldwide. The company owns Entadfi, an FDA-approved, once daily pill that combines finasteride and tadalafil for the treatment of benign prostatic hyperplasia. It is also developing a streptococcus pneumoniae vaccine candidate, which is designed to prevent infectious middle ear infections in children, and prevention of pneumonia in the elderly; and universal flu vaccine that provide protection from all virulent strains in addition to licensing a novel norovirus S&P nanoparticle versatile virus-like particle vaccine platform from Cincinnati Children's to develop vaccines for multiple infectious diseases, including Marburg and monkeypox, and others. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was incorporated in 2018 and is headquartered in Cincinnati, Ohio.
fullTimeEmployees§12
companyOfficers§[{'maxAge': 1, 'name': 'Mr. James R. Sapirstein M.B.A., R.Ph.', 'age': 62, 'title': 'Executive Chairman', 'yearBorn': 1961, 'fiscalYear': 2022, 'totalPay': 65625, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Erin  Henderson', 'age': 48, 'title': 'Consultant', 'yearBorn': 1975, 'fiscalYear': 2022, 'totalPay': 526905, 'exercisedValue': 114471, 'unexercisedValue': 5210}, {'maxAge': 1, 'name': 'Dr. Neil J. Campbell MA, MBA', 'age': 63, 'title': 'President, CEO & Director', 'yearBorn': 1960, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Bruce  Harmon', 'age': 65, 'title': 'Chief Financial Officer', 'yearBorn': 1958, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Brian  Price Ph.D.', 'title': 'Head of Technology Strategy', 'fiscalYear': 2022, 'totalPay': 126479, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Ralph  Schiess Ph.D.', 'age': 45, 'title': 'Chief Science Officer', 'yearBorn': 1978, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Frank A. Jaeger M.A., M.B.A.', 'age': 53, 'title': 'Senior VP of Marketing & Business Development', 'yearBorn': 1970, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Andrew D. Skibo Ph.D.', 'title': 'Global Head of Biologics Operations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Theodore Scott Yoho', 'title': 'Head of Business Development', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Ali I. Fattom Ph.D.', 'title': 'Head of Science & Discovery', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
currency§USD
dateShortInterest§1701302400
forwardEps§-0.85
exchange§NCM
quoteType§EQUITY
shortName§Onconetix, Inc.
longName§Onconetix, Inc.
firstTradeDateEpochUtc§1645194600
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§32a5d7e9-d675-3883-aeca-199596981307
gmtOffSetMilliseconds§-18000000
targetHighPrice§9.0
targetLowPrice§9.0
targetMeanPrice§9.0
targetMedianPrice§9.0
recommendationMean§3.0
recommendationKey§hold
numberOfAnalystOpinions§1
quickRatio§0.434
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
